COMMUNIQUÉS West-GlobeNewswire

Novartis Phase III study demonstrates adjuvant Tafinlar® + Mekinist® reduced the risk of disease recurrence by 53% in patients with resected BRAF V600 mutation-positive melanoma
11/09/2017
The three-year relapse-free survival (RFS) rate for patients treated with the combination was 58%, compared to 39% with placebo[1] Consistent improvement in RFS observed across all pre-specified subgroups, including [...]
Novartis presents new data at EURETINA 2017 confirming Lucentis® efficacy and durability vs aflibercept
09/09/2017
Interim results of the head-to-head RIVAL study confirm strong efficacy and comparable durability versus aflibercept in patients with nAMD Five-year results from the Lucentis LUMINOUS study, the largest ever in retinal [...]
L'Association internationale pour l'étude du cancer du poumon annonce des sélections de rapports pour la 18e Conférence mondiale sur le cancer du poumon
08/09/2017
Des travaux de recherche révolutionnaires mettront en lumière les progrès les plus récents dans l'étude du cancer du poumon DENVER, 2017-09-08 (GLOBE NEWSWIRE) -- L'Association internationale pour l'étude du cancer du [...]
LifeVantage Corporation élargit sa présence mondiale avec une expansion en Allemagne
08/09/2017
Les produits disponibles en Allemagne incluent le Synergizer Nrf2 Protandim® et TrueScience®, la crème antivieillissement pour les soins de la peau de la société SALT LAKE CITY, le 8 septembre 2017 (GLOBE NEWSWIRE) - [...]
PCI Biotech: Capital increase registered and listing of new shares
08/09/2017
Oslo, 8 September 2017 - Reference is made to the stock exchange notice of 5 September 2017 by PCI Biotech Holding ASA (the "Company") in respect of the issuance of 86,500 new shares following exercise of employee share [...]
Information from Infant Bacterial Therapeutics Capital Markets Day 2017
08/09/2017
Infant Bacterial Therapeutics has today, September 8, 2017, hosted a Capital Markets Day for investors, financial analysts and media in Stockholm. The purpose of the Capital Markets Day was to present Infant Bacterial [...]
Inivata: Inivata Announces Appointment of Dr Jamie Platt as Chief Operations Officer
08/09/2017
Inivata Announces Appointment of Dr Jamie Platt as Chief Operations Officer Research Triangle Park, NC and Cambridge, UK, September 8, 2017 -- Inivata , a global clinical cancer genomics company utilizing an industry- [...]
Medtronic Announces Japanese Regulatory Approval for the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon
08/09/2017
Clinically-Proven, Durable, Consistent, and Safe Market-Leading DCB Poised to Improve Outcomes for PAD Patients in Japan DUBLIN - September 8, 2017 - Medtronic plc (NYSE: MDT) today announced that the IN.PACT(TM)Admiral [...]
Nicox : Informations financières et point des activités du premier semestre 2017
08/09/2017
Communiqué de presse Nicox : Informations financières et point des activités du premier semestre 2017 Approbation de la demande d'autorisation de mise sur le marché ( New Drug Application , NDA) de ZERVIATE TM (solution [...]
Nicox first half 2017 business and financial update
08/09/2017
Press Release Nicox first half 2017 business and financial update ZERVIATE TM (cetirizine ophthalmic solution), 0.24% New Drug Application (NDA) approved Investigational New Drug (IND) submissions for NCX 470 for IOP [...]
Sanofi, Regeneron: Cemiplimab Receives FDA Breakthrough Designation for Advanced Cutaneous Squamous Cell Carcinoma
08/09/2017
Sanofi and Regeneron Announce That Cemiplimab (REGN2810) Has Received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma Paris, France and Tarrytown, New York - September 8, 2017 - [...]
Sanofi et Regeneron annoncent que la FDA a accordé la désignation de « Découverte capitale » au cemiplimab (REGN2810) dans le traitement du carcinome épidermoïde cutané au stade avancé
08/09/2017
Sanofi et Regeneron annoncent que la FDA a accordé la désignation de « Découverte capitale » au cemiplimab (REGN2810) dans le traitement du carcinome épidermoïde cutané au stade avancé Paris (France) et Tarrytown (New [...]
Novartis presents new analysis demonstrating AMG 334 (erenumab) significantly reduced monthly migraine days in patients who failed previous preventive therapies
07/09/2017
AMG 334 (erenumab) delivered consistent reductions in monthly migraine days for patients with chronic migraine and prior treatment failure, a population with significant unmet need Dedicated cardiovascular safety study [...]
LifeVantage Corporation Increases Global Footprint with Expansion into Germany
07/09/2017
Products available in Germany include Protandim® Nrf2 Synergizer and the company's TrueScience® Anti-Aging Skin Care Regimen SALT LAKE CITY, Sept. 07, 2017 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), [...]
XBiotech annonce la présentation des données de l'étude de phase 2 pour l'évaluation de MABp1 dans le traitement de l'hidradénite suppurée
07/09/2017
Résultats de l'étude de phase 2 randomisée pour l'évaluation de MABp1 dans le traitement de l'hidradénite suppurée AUSTIN, Texas, le 7 septembre 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd' [...]
The International Association for the Study of Lung Cancer Announces Abstract Selections for the 18th World Conference on Lung Cancer
07/09/2017
Groundbreaking research will shed light on the newest advances in the study of lung cancer DENVER, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The International Association for the Study of Lung Cancer (IASLC) announced today [...]
Inivata: Announces Strategic Partnership with Levine Cancer Institute and Formation of the Inivata Knowledge Accumulation Network
07/09/2017
Inivata Announces Strategic Partnership with Levine Cancer Institute and Formation of the Inivata Knowledge Accumulation Network This network will bring together global leaders in cancer care to unlock the potential of [...]
SPINEWAY : Poursuite du déploiement aux USA Nouveau distributeur au Texas
07/09/2017
Communiqué de presse Ecully, le 7 septembre 2017 Poursuite du déploiement aux USA Nouveau distributeur au Texas Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des pathologies de la [...]
SPINEWAY : Continued expansion in the USA New distributor in Texas
07/09/2017
Press release Ecully, 7 September 2017 Continued expansion in the USA New distributor in Texas Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has just [...]

Pages